These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30379814)

  • 1. An open label randomized clinical trial comparing the safety and effectiveness of one, two or three weekly pentamidine isethionate doses (seven milligrams per kilogram) in the treatment of cutaneous leishmaniasis in the Amazon Region.
    Gadelha EPN; Ramasawmy R; da Costa Oliveira B; Morais Rocha N; de Oliveira Guerra JA; Allan Villa Rouco da Silva G; Gabrielle Ramos de Mesquita T; Chrusciak Talhari Cortez C; Chrusciak Talhari A
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006850. PubMed ID: 30379814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failure.
    Christen JR; Bourreau E; Demar M; Lightburn E; Couppié P; Ginouvès M; Prévot G; Gangneux JP; Savini H; de Laval F; Pommier de Santi V; Briolant S
    Travel Med Infect Dis; 2018; 24():31-36. PubMed ID: 29482012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.
    Oliveira LF; Schubach AO; Martins MM; Passos SL; Oliveira RV; Marzochi MC; Andrade CA
    Acta Trop; 2011 May; 118(2):87-96. PubMed ID: 21420925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana.
    Roussel M; Nacher M; Frémont G; Rotureau B; Clyti E; Sainte-Marie D; Carme B; Pradinaud R; Couppié P
    Ann Trop Med Parasitol; 2006 Jun; 100(4):307-14. PubMed ID: 16762111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis.
    Neves LO; Talhari AC; Gadelha EP; Silva Júnior RM; Guerra JA; Ferreira LC; Talhari S
    An Bras Dermatol; 2011; 86(6):1092-101. PubMed ID: 22281895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam.
    Lai A Fat EJ; Vrede MA; Soetosenojo RM; Lai A Fat RF
    Int J Dermatol; 2002 Nov; 41(11):796-800. PubMed ID: 12453009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring the response of patients with cutaneous leishmaniasis to treatment with pentamidine isethionate by quantitative real-time PCR, and identification of Leishmania parasites not responding to therapy.
    Mans DR; Kent AD; Hu RV; Lai A Fat EJ; Schoone GJ; Adams ER; Rood EJ; Alba S; Sabajo LO; Lai A Fat RF; de Vries HJ; Schallig HD
    Clin Exp Dermatol; 2016 Aug; 41(6):610-5. PubMed ID: 26648589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of American cutaneous leishmaniasis. Outcome apropos of 326 cases treated with high-dose pentamidine isethionate].
    Lightburn E; Morand JJ; Meynard JB; Kraemer P; Chaudier B; Pages F; Garnotel E; Patte JH; Banzet S; Dampierre H; Lepage J; Morillon M; Boutin JP; Hovette P; Chouc C
    Med Trop (Mars); 2003; 63(1):35-44. PubMed ID: 12891748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Old World cutaneous leishmaniasis by pentamidine isethionate. An open study of 11 patients.
    Hellier I; Dereure O; Tournillac I; Pratlong F; Guillot B; Dedet JP; Guilhou JJ
    Dermatology; 2000; 200(2):120-3. PubMed ID: 10773699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial.
    Francesconi VA; Francesconi F; Ramasawmy R; Romero GAS; Alecrim MDGC
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006225. PubMed ID: 29481560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of treatment with pentamidine for cutaneous leishmaniasis in Suriname.
    van der Meide WF; Sabajo LO; Jensema AJ; Peekel I; Faber WR; Schallig HD; Fat RF
    Int J Dermatol; 2009 Jan; 48(1):52-8. PubMed ID: 19126051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia.
    López L; Vélez I; Asela C; Cruz C; Alves F; Robledo S; Arana B
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006653. PubMed ID: 30044792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a single dose pentamidine (7mg/kg) for patients with cutaneous leishmaniasis caused by L. guyanensis: a pilot study.
    Gadelha EP; Talhari S; Guerra JA; Neves LO; Talhari C; Gontijo B; Silva Junior RM; Talhari AC
    An Bras Dermatol; 2015; 90(6):807-13. PubMed ID: 26734860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis associated with pentamidine isethionate therapy for American cutaneous leishmaniasis.
    Delobel P; Pradinaud R
    J Antimicrob Chemother; 2003 May; 51(5):1319-20. PubMed ID: 12668576
    [No Abstract]   [Full Text] [Related]  

  • 15. To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL).
    Rabi Das VN; Siddiqui NA; Pal B; Lal CS; Verma N; Kumar A; Verma RB; Kumar D; Das P; Pandey K
    PLoS One; 2017; 12(3):e0174497. PubMed ID: 28355259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of american cutaneous leishmaniasis, with lesions in the mucosa, using pentamidine isethionate].
    Amato VS; de Paula JG; Imamura R; Amato Neto V; Duarte MI; Boulos MI; Boulos M; Nicodemo AC; de Mendonca JS
    Rev Soc Bras Med Trop; 1996; 29(5):477-81. PubMed ID: 8966312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20mgSbV/day for 20 days to treat cutaneous leishmaniasis].
    de Paula CD; Sampaio JH; Cardoso DR; Sampaio RN
    Rev Soc Bras Med Trop; 2003; 36(3):365-71. PubMed ID: 12908038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using pentamidine to treat cutaneous leishmaniasis in children: a 10-year study in French Guiana.
    Heleine M; Elenga N; Njuieyon F; Martin E; Piat C; Pansart C; Couppie P; Hernandez M; Demar M; Blaizot R
    Clin Exp Dermatol; 2023 Jul; 48(8):913-915. PubMed ID: 37075241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, Safety, and Dose of Pafuramidine, a New Oral Drug for Treatment of First Stage Sleeping Sickness, in a Phase 2a Clinical Study and Phase 2b Randomized Clinical Studies.
    Burri C; Yeramian PD; Allen JL; Merolle A; Serge KK; Mpanya A; Lutumba P; Mesu VK; Bilenge CM; Lubaki JP; Mpoto AM; Thompson M; Munungu BF; Manuel F; Josenando T; Bernhard SC; Olson CA; Blum J; Tidwell RR; Pohlig G
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004362. PubMed ID: 26881924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cutaneous leishmaniasis with a sequential scheme of pentamidine and tamoxifen in an area with a predominance of Leishmania (Viannia) guyanensis: A randomised, non-inferiority clinical trial.
    Pennini SN; de Oliveira Guerra JA; Rebello PFB; Abtibol-Bernardino MR; de Castro LL; da Silva Balieiro AA; de Oliveira Ferreira C; Noronha AB; Dos Santos da Silva CG; Leturiondo AL; Vital de Jesus D; de Araújo Santos FJ; Chrusciak-Talhari A; Guerra MDGVB; Talhari S
    Trop Med Int Health; 2023 Dec; 28(12):871-880. PubMed ID: 37936525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.